Visit Virbac at WVC

Virbac is very excited to be a sponsor at the upcoming WVC Annual Conference (Western Veterinary Conference) in Las Vegas, Nevada from March 2nd to 5th, 2025. Please stop by booth #1851 to meet the team and learn about our wonderful products, including:

• URSOLYX™ Soft Chews
• VETERINARY HPM^® Pet Nutrition
• STELFONTA^® (tigilanol tiglate injection)
• EASOTIC^® (hydrocortisone aceponate, miconazole nitrate, gentamicin sulfate) Otic Suspension for Dogs
• MOVOFLEX^® ADVANCED Soft Chews

Come join us to learn more about all the exciting things happening at Virbac. We look forward to seeing you there!

 

 

Monday, March 3rd

8:00AM - 8:50 AM

Why Weight? Flipping the Script in the Exam Room for Proactive Weight Management

• Ernie Ward, DVM, CVFT
• Emily Luisana, DVM, DACVIM (Nutrition)
• Ashley Self, LVMT, VTS (Nutrition)
• Mandalay Bay B, Level 2
• 1 CE Credit

 

10:00AM - 10:50AM

Muscle Matters: Revolutionizing Canine Mobility with Ursolic Acid

• Chris M. Adams, M.D., Ph.D.
• Leilani Alvarez, DVM, DACVSMR
• Mandalay Bay B, Level 2
• 1 CE Credit

 

11:00 AM - 11:50 AM

Skin Infections: Latest Insights on Therapy for Quick Resolution and Long Term Success

• Jason Pieper, DVM, DACVD
• Mandalay Bay B, Level 2
• 1 CE Credit

 

 

Tuesday, March 4th

10:00 AM - 10:50 AM

Canine Skin Cancers: The Essential Role of the Veterinary Technician

• Jamie Rauscher, LVT
• Mandalay Bay B, Level 2
• 1 CE Credit

 

11:00 AM - 11:50 AM

Feline Anxiety: When Enrichment Isn't Enough

• Meghan Herron DVM, DACVB
• Mandalay Bay B, Level 2
• 1 CE Credit

 

2:00 PM - 2:50 PM

Shake It Off! A Fear Free Approach to Otitis Externa

• Brittany Lancellotti, DVM, DACVD
• Mandalay Bay B, Level 2
• 1 CE Credit

 

3:00 PM - 3:50 PM

Spectrum of Care: Closing the Gap on Heartworm Prevention

• Angele Bice, DVM
• Mandalay Bay B, Level 2
• 1 CE Credit

 

IMPORTANT SAFETY INFORMATION

STELFONTA^® (tigilanol tiglate injection): Accidental self-injection of STELFONTA^® (tigilanol tiglate injection) may cause severe wound formation. To decrease the risk of accidental self-injection, sedation of the dog may be  necessary. In dogs, do not inject STELFONTA into subcutaneous mast cell tumors located above  the elbow or hock. Formation of wounds, possibly extensive, is an intended and likely response  to treatment with STELFONTA along with associated swelling, bruising and pain; these wounds  are expected to heal. Appropriate pre- and post-treatment medications must be given,  including a corticosteroid plus blocking agents for both H1 and H2 receptors, in order to  decrease the potential for severe systemic adverse reactions, including death, from mast cell  degranulation. For full prescribing information, contact VIRBAC at 1-800-338-3659 or download here.

EASOTIC^® (hydrocortisone aceponate, miconazole nitrate, gentamicin sulfate) Otic Suspension for Dogs: For otic (ear) use in dogs only. Contraindicated in dogs with known or suspected hypersensitivity to corticosteroids, imidazole antifungals, or aminoglycoside antibiotics. Do not use in dogs with known tympanic membrane (ear drum) perforation. The safe use of EASOTIC Otic Suspension in dogs used for breeding purposes has not been evaluated. Do not administer orally.  Humans with known or suspected hypersensitivity to hydrocortisone, aminoglycoside antibiotics, or azole antifungals should not handle this product. For complete information or to obtain a package insert, contact  Virbac at 1‐800‐338‐3659, or download here.